Home › Funds › Capital World Investors › VRTX

Capital World Investors position in VRTX

VERTEX PHARMACEUTICALS INCORPORATED · Health Care

Latest position (Q2 2026)26.12M sh
Reported value held$12.97B
Portfolio Weight1.62%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 11.04M $2.00B New
Q4 2021 11.52M $2.53B Add
Q1 2022 12.67M $3.31B Add
Q2 2022 12.57M $3.54B Reduce
Q3 2022 12.52M $3.63B Hold
Q4 2022 12.77M $3.69B Add
Q1 2023 16.14M $5.09B Add
Q2 2023 17.34M $6.10B Add
Q3 2023 17.98M $6.25B Add
Q4 2023 21.81M $8.87B Add
Q1 2024 25.57M $10.69B Add
Q2 2024 26.71M $12.52B Add
Q3 2024 26.81M $12.47B Hold
Q4 2024 28.33M $11.41B Add
Q1 2025 28.53M $13.83B Add
Q2 2025 28.73M $12.79B Add
Q3 2025 25.91M $10.15B Reduce
Q4 2025 25.51M $11.57B Reduce
Q1 2026 25.37M $11.33B Reduce
Q2 2026 26.12M $12.97B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding VRTX

All VRTX fund holders →